Repligen reported $553K in Ordinary Share Capital for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Biomarin Pharmaceutical BMRN:US $ 0.18M 0M
Bristol Myers Squibb BMY:US $ 292M 0M
Catalent CTLT:US $ 2M 0M
Charles River Laboratories CRL:US $ 0.51M 0M
Danaher DHR:US $ 9M 0M
Dentsply International XRAY:US 3M 0
Exact Sciences EXAS:US $ 1.72M 0M
Fluidigm FLDM:US $ 0.08M 0M
General Electric GE:US $ 15M 687M
Henry Schein HSIC:US $ 1.39M 0.01M
Illumina ILMN:US $ 2M 0M
IQVIA Holdings Inc IQV:US $ 2.56M 444K
Luminex LMNX:US $ 0.05M 0M
Mettler Toledo International MTD:US 448K 0
Myriad Genetics MYGN:US $ 0.8M 0M
Nanostring Technologies NSTG:US $ 0M 0M
Patterson Companies PDCO:US $ 0.97M 0M
Peregrine Pharmaceuticals PPHM:US $ 0.06M 0M
Repligen RGEN:US $ 0.55M 0M
West Pharmaceutical Services WST:US $ 18.8M 0M